Thursday, June 5, 2014

Well, here's a pretty damning article from the Annals of Internal Medicine about the ethics of cancer centers, "What are cancer centers advertising to the public?"  Excerpt from the abstract: 

Background: Although critics have expressed concerns about cancer center advertising, analyses of the content of these advertisements are lacking.

Objective: To characterize the informational and emotional content of direct-to-consumer cancer center advertisements.

Design: Content analysis. 

Setting: Top U.S. consumer magazines (n  = 269) and television networks (n  = 44) in 2012. 

Measurements: Types of clinical services promoted; information provided about clinical services, including risks, benefits, costs, and insurance availability; use of emotional advertising appeals; and use of patient testimonials were assessed. Two investigators independently coded advertisements using ATLAS.ti, and κ values ranged from 0.77 to 1.00. 

Results: A total of 102 cancer centers placed 409 unique clinical advertisements in top media markets in 2012. Advertisements promoted treatments (88%) more often than screening (18%) or supportive services (13%). Benefits of advertised therapies were described more often than risks (27% vs. 2%) but were rarely quantified (2%). Few advertisements mentioned coverage or costs (5%), and none mentioned specific insurance plans. Emotional appeals were frequent (85%), evoking hope for survival (61%), describing cancer treatment as a fight or battle (41%), and inducing fear (30%). Nearly one half of advertisements included patient testimonials, which were usually focused on survival, rarely included disclaimers (15%), and never described the results that a typical patient may expect. 

Limitation: Internet advertisements were not included. 

Conclusion: Clinical advertisements by cancer centers frequently promote cancer therapy with emotional appeals that evoke hope and fear while rarely providing information about risks, benefits, costs, or insurance availability.

Related Posts:

  • A protracted failure of American medicine to self regulateScott Gottlieb, writing at Forbes, says:The “Physician Sunshine Act” is as much a response to the past marketing excesses of the drug and device makers as a reflection of the retreating stature of the American doctor. Aspec… Read More
  • Is this part of the promised lower costs?The Boston Globe's Robert Weisman summarizes the effect of the tax on insurers imposed by the Accountable Care Act.  Excerpts:Insurance companies, like drug and medical device makers, were required to help fund the Affo… Read More
  • Save a Child's HeartMIT student Noah Buckman writes:I’m writing to you about a fundraiser I have been working on these past few months with my fraternity, AEPi, for Save A Child’s Heart.  Our campaign has been a major success and it’s be… Read More
  • Selling out to PartnersIf this newspaper story by Robert Weisman at the Boston Globe is correct, the Attorney General is about to sign an agreement with Partners Healthcare System that will lock in the system's dominance for years to come.The main … Read More
  • Failing to act as stewards of the occupation’s standardsThere continue to be lots of stories about the high cost of the new drugs to combat hepatatis C.  Here's one from NPR by Melissa Block and Richard Knox. In a previous post, I talked about the presence of  a distingu… Read More

0 comments:

Post a Comment

Blog Archive

Powered by Blogger.

Popular Posts